BioSpace News Archive

Genetown

Vericel to Present at the Stephens Annual Investment Conference

Vericel Corporation today announced that Nick Colangelo, President and CEO and Joe Mara, CFO will present at the Stephens Annual Investment Conference.

November 7, 2023
·
1 min read
Business

IDEAYA Biosciences, Inc. Reports Third Quarter 2023 Financial Results and Provides Business Update

IDEAYA Biosciences, Inc., a precision medicine oncology company committed to the discovery and development of targeted therapeutics, provided a business update and announced financial results for the third quarter ended September 30, 2023.

November 7, 2023
·
29 min read
Business

Mallinckrodt plc (in Examinership) Reports Third Quarter 2023 Financial Results

Mallinckrodt plc, a global specialty pharmaceutical company, reported its financial results for the third quarter ended September 29, 2023.

November 7, 2023
·
40 min read
Business

SOPHiA GENETICS Reports Financial Results for the Third Quarter of Fiscal 2023 Record results on growth acceleration, significant improvement in operating loss and cash burn

SOPHiA GENETICS SA, a cloud-native software company and a leader in data-driven medicine, reported financial results for the third quarter ended September 30, 2023.

November 7, 2023
·
22 min read
Business

Immunic to Announce Financial Results for the Third Quarter Ended September 30, 2023, and Provide Corporate Update

Immunic, Inc. announced that the company will release its financial results for the third quarter ended September 30, 2023, including a corporate update, on Tuesday, November 14, 2023, before the opening of the U.S.

November 7, 2023
·
5 min read
Genetown

BioReference® Signs On as the First Laboratory to Use MSK-ACCESS® Powered with SOPHiA DDM™

SOPHiA GENETICS announced that BioReference® Health, LLC, an OPKO Health, Inc. company and full-service laboratory that processes more than 12 million tests annually, will implement SOPHiA GENETICS’ technology and add MSK-ACCESS® liquid biopsy to its test suite.

November 7, 2023
·
6 min read
AC Immune to Present at the Jefferies 2023 London Healthcare Conference

AC Immune SA announced that Company Management will participate in a fireside chat and one-on-one investor meetings during the Jefferies 2023 London Healthcare Conference, taking place in-person in London on November 14-16, 2023.

November 7, 2023
·
3 min read
Business

ProQR Announces Third Quarter 2023 Operating and Financial Results

ProQR Therapeutics NV. reported its financial and operating results for the third quarter ended September 30, 2023, and provided a business update.

November 7, 2023
·
15 min read
Business

Immunocore Reports Third Quarter 2023 Financial Results and Provides Business Update

Immunocore Holdings plc announced its financial results for the third quarter ended September 30, 2023, and provided a business update.

November 7, 2023
·
23 min read
Genetown

Lyra Therapeutics to Participate in Upcoming November 2023 Investor Conferences

Lyra Therapeutics, Inc. announced that Maria Palasis, Ph.D., President and Chief Executive Officer, will participate in the following investor conferences in November

November 7, 2023
·
1 min read